ATAI

AtaiBeckley Inc.

Latest Form 4:Sale$496KbyHERSHBERG ROBERT (Director) · filed Jul 9, 2026

AtaiBeckley Inc. (ATAI) has 8 SEC Form 4 filings (19 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Jul 9, 2026.

The most active filer is Chief Medical Officer Craig Kevin James with 3 filings. Insiders have net sold $1.5M over the trailing 6 months.

  • Industry:Biotechnology
  • CEO:Christian Angermayer
  • Employees:99
  • HQ:New York, NY, US
  • IPO:2021-06-18

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$1.7M

reported sales (SEC code S)

Unique Insiders

4

in the rolling window

Market Cap

$2.7B

latest known value

Source
HERSHBERG ROBERTFirst in 7 months
Sale$496KJul 9SEC ↗
Sale$192KJun 29SEC ↗
Kochendoerfer GerdFirst filing
Sale$250KJun 29SEC ↗
Sale$213KApr 22SEC ↗
Craig Kevin JamesFirst filing
Sale$355KMar 24SEC ↗
Sale$154KJan 6SEC ↗

Related companies

AtaiBeckley Inc. is in the Healthcare sector.